Skip to main content
Caplight Logo









Element Science

Element Science

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://elementscience.com/

Last Round

Series C

Mar 3, 2020

Total Funding Raised

$192.6M

Company Overview

Element Science is a medical device and digital health company that develops wearable therapeutic devices utilizing data science and machine learning to protect patients with heart disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Data as a Service

AI Layer

Application

Keywords

wearable cardioverter defibrillatorWCDcardiac monitoringremote patient monitoringRPMdigital healtharrhythmia detectionmedical devicewearable health techmedtechcardiovascular caredefibrillation therapyFDA approved deviceclinical monitoringconnected health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Element Science Comparables

Compare Element Science with similar companies based on industry and business-model similarity.

Element Science comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kestra Medical Technologies
88%
Asahi Kasei
83%
Philips
70%

Element Science Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 3, 2020
DebtAug 29, 2019
Series BAug 12, 2016
Series AFeb 13, 2014

Key People

Founding team and executive leadership

Douglas Devine

Chief Executive Officer

Executive Team

Eric Samuels

Interim Chief Financial Officer

Executive Team

Element Science Investors

Notable investors and investment history

Element Science investors
InvestorRounds
Deerfield ManagementSeries C
GVSeries A, Series C, Series B
Invus OpportunitiesSeries C
QimingSeries C
Northview LifeSciencesSeries C
Cormorant Asset ManagementSeries C
Third Rock VenturesSeries C, Series B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 21, 2025

    Wearable cardioverter defibrillator now commercially available after PMA approval.

  • Mar 3, 2020

    $146M round closed.

Element Science Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Element Science Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Element Science's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range90
Year Founded2011
Last FundingMar 3, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?